Cytomegalovirus Pneumonia in a Patient with Down Syndrome
Abstract
:1. Introduction
2. Case Presentation
3. Discussion
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Shepperd, S.; Farndon, P.; Grainge, V.; Oliver, S.; Parker, M.; Perera, R.; Bedford, H.; Elliman, D.; Kent, A.; Rose, P. DIS-CERN-Genetics: Quality criteria for information on genetic testing. Eur. J. Hum. Genet. 2006, 14, 1179–1188. [Google Scholar] [CrossRef] [PubMed]
- Blake, J.M.; Estrada Gomez, D.; Skotko, B.G.; Torres, A.; Santoro, S.L. Pneumonia and respiratory infection in Down syndrome: A 10-year cohrt analysis of inpatient and outpatient encounters across the lifespan. Am. J. Med. Genet. 2021, 185, 2878–2887. [Google Scholar] [CrossRef] [PubMed]
- Bittles, A.H.; Bower, C.; Hussain, R.; Glasson, E.J. The four ages of Down syndrome. Eur. J. Public Health 2007, 17, 221–225. [Google Scholar] [CrossRef] [PubMed]
- Santoro, S.L.; Chicoine, B.; Jasien, J.M.; Kim, J.L.; Stephens, M.; Bulova, P.; Capone, G. Pneumonia and respiratory infections in Down syndrome: A scoping review of the literature. Am. J. Med. Genet. 2021, 185, 286–299. [Google Scholar] [CrossRef] [PubMed]
- Ljungman, P.; Griffiths, P.; Paya, C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin. Infect. Dis. 2002, 34, 1094–1097. [Google Scholar] [CrossRef] [PubMed]
- Beam, E.; Germer, J.J.; Lahr, B.; Yao, J.D.; Limper, A.H.; Binnicker, M.J.; Razonable, R.R. Cytomegalovirus (CMV) DNA quantification in bronchoalveolar lavage fluid of immunocompromised patients with CMV pneumonia. Clin. Transpl. 2018, 32, e13149. [Google Scholar] [CrossRef]
- Durand, C.M.; Marr, K.A.; Arnold, C.A.; Tang, L.; Durand, D.J.; Avery, R.K.; Valsamakis, A.; Neofytos, D. Detection of cytomegalovirus DNA in plasma as an adjunct diagnostic for gastrointestinal tract disease in kidney and liver transplant recipients. Clin. Infect. Dis. 2013, 57, 1550–1559. [Google Scholar] [CrossRef]
- Janoff, E.N.; Tseng, H.F.; Nguyen, J.L.; Alfred, T.; Vietri, J.; McDaniel, A.; Chilson, E.; Yan, Q.; Malhotra, D.; Isturiz, R.E.; et al. Incidence and clinical outcomes of pneumonia in persons with down syndrome in the United States. Vaccine 2023, 41, 4571–4578. [Google Scholar] [CrossRef]
- Schmidt, G.M.; Horak, D.A.; Niland, J.C.; Duncan, S.R.; Forman, S.J.; Zaia, J.A.; The City of Hope-Stanford-Syntex CMV Study Group. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. N. Engl. J. Med. 1991, 324, 1005–1010. [Google Scholar] [CrossRef]
- Boeckh, M.; Ljungman, P. How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood 2009, 113, 5711–5719. [Google Scholar] [CrossRef]
- Fishman, J.A. Infection in solid-organ transplant recipients. N. Engl. J. Med. 2007, 357, 2601–2614. [Google Scholar] [CrossRef]
- Hill, R.B., Jr.; Rowlands, D.T., Jr.; Rifkind, D. Infectious Pulmonary Disease in Patients Receiving Immunosuppressive Therapy for Organ Transplantation. N. Engl. J. Med. 1964, 271, 1021–1027. [Google Scholar] [CrossRef]
- Snyder, L.D.; Finlen-Copeland, C.A.; Turbyfill, W.J.; Howell, D.; Willner, D.A.; Palmer, S.M. Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation. Am. J. Respir. Crit. Care Med. 2010, 181, 1391–1396. [Google Scholar] [CrossRef] [PubMed]
- Wallace, J.M.; Hannah, J. Cytomegalovirus pneumonitis in patients with AIDS. Findings in an autopsy series. Chest 1987, 92, 198–203. [Google Scholar] [CrossRef] [PubMed]
- Szczawinska-Poplonyk, A.; Jonczyk-Potoczna, K.; Ossowska, L.; Breborowicz, A.; Bartkowska-Sniatkowska, A.; Wachowiak, J. Cytomegalovirus pneumonia as the first manifestation of severe combined immunodeficiency. Cent. Eur. J. Immunol. 2014, 39, 392–395. [Google Scholar] [CrossRef] [PubMed]
- Cunha, B.A.; Pherez, F.; Walls, N. Severe cytomegalovirus (CMV) community-acquired pneumonia (CAP) in a non immuno-compromised host. Heart Lung 2009, 38, 243–248. [Google Scholar] [CrossRef] [PubMed]
- Grilli, E.; Galati, V.; Bordi, L.; Taglietti, F.; Petrosillo, N. Cytomegalovirus pneumonia in immunocompetent host: Case report and literature review. J. Clin. Virol. 2012, 55, 356–359. [Google Scholar] [CrossRef]
- Goncalves, C.; Cipriano, A.; Videira Santos, F.; Abreu, M.; Mendez, J.; Sarmento, E.C.R. Cytomegalovirus acute infection with pulmonary involvement in an immunocompetent patient. IDCases 2018, 14, e00445. [Google Scholar] [CrossRef] [PubMed]
- Rafailidis, P.I.; Mourtzoukou, E.G.; Varbobitis, I.C.; Falagas, M.E. Severe cytomegalovirus infection in apparently immuno-competent patients: A systematic review. Virol. J. 2008, 5, 47. [Google Scholar] [CrossRef] [PubMed]
- Moon, J.H.; Kim, E.A.; Lee, K.S.; Kim, T.S.; Jung, K.J.; Song, J.H. Cytomegalovirus pneumonia: High-resolution CT findings in ten non-AIDS immunocompromised patients. Korean J. Radiol. 2000, 1, 73–78. [Google Scholar] [CrossRef]
- Boeckh, M.; Murphy, W.J.; Peggs, K.S. Recent Advances in Cytomegalovirus: An Update on Pharmacologic and Cellular Therapies. Biol. Blood Marrow Transpl. 2014, 21, 24–29. [Google Scholar] [CrossRef]
- Razonable, R.R.; Humar, A. Cytomegalovirus in solid organ transplantation. Am. J. Transpl. 2013, 13 (Suppl. S4), 93–106. [Google Scholar] [CrossRef] [PubMed]
- Kotton, C.N.; Kumar, D.; Caliendo, A.M.; Åsberg, A.; Chou, S.; Danziger-Isakov, L.; Humar, A.; Transplantation Society International CMV Consensus Group. Updated international consensus guidelines on the management of cytomeg-alovirus in solid-organ transplantation. Transplantation 2013, 96, 333–360. [Google Scholar] [CrossRef]
- Chemaly, R.F.; Yen-Lieberman, B.; Castilla, E.A.; Reilly, A.; Arrigain, S.; Farver, C.; Avery, R.K.; Gordon, S.M.; Procop, G.W. Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry. J. Clin. Microbiol. 2004, 42, 2168–2172. [Google Scholar] [CrossRef] [PubMed]
- Tan, S.K.; Burgener, E.B.; Waggoner, J.J.; Gajurel, K.; Gonzalez, S.; Chen, S.F.; Pinsky, B.A. Molecular and Culture -Based Bronchoalveolar Lavage Fluid Testing for the Diagnosis of Cytomegalovirus Pneumonitis. Open Forum Infect. Dis. 2015, 3, ofv212. [Google Scholar] [CrossRef]
- Hayden, R.T.; Yan, X.; Wick, M.T.; Rodriguez, A.B.; Xiong, X.; Ginocchio, C.C.; Mitchell, M.J.; Caliendo, A.M. Factors contributing to variability of quantitative viral PCR results in proficiency testing samples: A multivariate analysis. J. Clin. Microbiol. 2012, 50, 337–345. [Google Scholar] [CrossRef] [PubMed]
- Preiksaitis, J.K.; Hayden, R.T.; Tong, Y.; Pang, X.L.; Fryer, J.F.; Heath, A.B.; Cook, L.; Petrich, A.K.; Yu, B.; Caliendo, A.M. Are we there yet? Impact of the first international standard for cytomegalovirus DNA on the harmonization of results reported on plasma samples. Clin. Infect. Dis. 2016, 63, 583–589. [Google Scholar] [CrossRef] [PubMed]
- Naegele, K.; Lautenschlager, I.; Gosert, R.; Loginov, R.; Bir, K.; Helanterä, I.; Schaub, S.; Khanna, N.; Hirsch, H.H. Cytomegalovirus sequence variability, amplicon length, and DNase-sensitive non-encapsidated genomes are obstacles to standardization and commutability of plasma viral load results. J. Clin. Virol. 2018, 104, 39–47. [Google Scholar] [CrossRef] [PubMed]
- Dioverti, M.V.; Lahr, B.D.; Germer, J.J.; Yao, J.D.; Gartner, M.L.; Razonable, R.R. Comparison of standardized cytomegalovirus (CMV) viral load thresholds in whole blood and plasma of solid organ and hematopoietic stem cell transplant recipients with CMV in-fection and disease. Open Forum Infect. Dis. 2017, 4, ofx143. [Google Scholar] [CrossRef]
- Boeckh, M.; Stevens-Ayers, T.; Travi, G.; Huang, M.L.; Cheng, G.S.; Xie, H.; Leisenring, W.; Erard, V.; Seo, S.; Kimball, L.; et al. Cytomegalovirus (CMV) DNA quantitation in bronchoalveolar lavage fluid from hematopoietic stem cell transplant recipients with CMV pneumonia. J. Infect. Dis. 2017, 215, 1514–1522. [Google Scholar] [CrossRef]
- Restrepo-Gualteros, S.M.; Gutierrez, M.J.; Villamil-Osorio, M.; Arroyo, M.A.; Nino, G. Challenges and Clinical Implications of the Diagnosis of Cytomegalovirus Lung Infection in Children. Curr. Infect. Dis. Rep. 2019, 21, 24. [Google Scholar] [CrossRef]
- Govender, K.; Jeena, P.; Parboosing, R. Clinical utility of bronchoalveolar lavage cytomegalovirus viral loads in the diagnosis of cytomegalovirus pneumonitis in infants. J. Med. Virol. 2017, 89, 1080–1087. [Google Scholar] [CrossRef] [PubMed]
- Lee, H.Y.; Rhee, C.K.; Choi, J.Y.; Lee, H.Y.; Lee, J.W.; Lee, D.G. Diagnosis of cytomegalovirus pneumonia by quantitative polymerase chain reaction using bronchial washing fluid from patients with hematologic malignancies. Oncotarget 2017, 8, 39736–39745. [Google Scholar] [CrossRef]
- Erard, V.; Guthrie, K.A.; Seo, S.; Smith, J.; Huang, M.; Chien, J.; Flowers, M.E.; Corey, L.; Boeckh, M. Reduced Mortality of Cytomegalovirus Pneumonia after Hematopoietic Cell Transplantation Due to Antiviral Therapy and Changes in Transplantation Practices. Clin. Infect. Dis. 2015, 61, 31–39. [Google Scholar] [CrossRef] [PubMed]
- Canto, C.L.; Granato, C.F.; Garcez, E.; Villas Boas, L.S.; Fink, M.C.D.S.; Estevam, M.P.; Pannuti, C.S. Cytomegalovirus infection in children with Down syndrome in a day-care center in Brazil. Rev. Inst. Med. Trop. Sao Paulo 2000, 42, 179–183. [Google Scholar] [CrossRef] [PubMed]
- Majithia, M.; Ribeiro, S.P. COVID-19 and down syndrome. Nat. Rev. Immunol. 2022, 22, 404–405. [Google Scholar] [CrossRef] [PubMed]
- Hill, D.A.; Gridley, G.; Cnattingius, S.; Mellemkjaer, L.; Linet, M.; Adami, H.O.; Olsen, J.H.; Nyren, O.; Fraumeni, J.F. Mortality and cancer incidence among individuals with Down syndrome. Arch. Intern. Med. 2003, 163, 705–711. [Google Scholar] [CrossRef]
- Marcovecchio, G.E.; Bortolomai, I.; Ferrua, F.; Fontana, E.; Imberti, L.; Conforti, E.; Amodio, D.; Bergante, S.; Macchiarulo, G.; D’Oria, V.; et al. Thymic epithelium abnormalities in DiGeorge and Down syndrome patients contribute to dysregulation in T cell development. Front. Immunol. 2019, 10, 447. [Google Scholar] [CrossRef]
- Satgé, D.; Seidel, M.G. The pattern of malignancies in Down syndrome and its potential context with the immune system. Front. Immunol. 2018, 9, 3058. [Google Scholar] [CrossRef]
- Kusters, M.A.; Verstegen, R.H.; Gemen, E.F.; de Vries, E. Intrinsic defect of the immune system in children with Down syn-drome: A review. Clin. Exp. Immunol. 2009, 156, 189–193. [Google Scholar] [CrossRef]
- Valentini, D.; Cotugno, N.; Scoppola, V.; Di Camillo, C.; Colagrossi, L.; Manno, E.C.; Perno, C.F.; Russo, C.; Palma, P.; Rossi, P.; et al. Safety and long-term immunogenicity of BNT162b2 vaccine in individuals with Down syndrome. J. Clin. Med. 2022, 11, 694. [Google Scholar] [CrossRef] [PubMed]
- Joshi, A.Y.; Abraham, R.S.; Snyder, M.R.; Boyce, T.G. Immune evaluation and vaccine responses in Down syndrome: Evidence of immunodeficiency? Vaccine 2011, 29, 5040–5046. [Google Scholar] [CrossRef]
- Fourati, S.; Cristescu, R.; Loboda, A.; Talla, A.; Filali, A.; Railkar, R.; Schaeffer, A.K.; Favre, D.; Gagnon, D.; Peretz, Y.; et al. Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination. Nat. Commun. 2016, 7, 10369. [Google Scholar] [CrossRef] [PubMed]
- Stagliano, D.R.; Nylund, C.M.; Eide, M.B.; Eberly, M.D. Children with Down syndrome are high-risk for severe respiratory syncytial virus disease. J. Pediatr. 2015, 166, 703–709.e2. [Google Scholar] [CrossRef] [PubMed]
- Kusters, M.A.A.; Manders, N.C.C.; de Jong, B.A.W.; van Hout, R.W.N.M.; Rijkers, G.T.; de Vries, E. Functionality of the pneumococcal antibody response in Down syndrome subjects. Vaccine 2013, 31, 6261–6265. [Google Scholar] [CrossRef]
- Nurmi, T.; Leinonen, M.; Häivä, V.M.; Tiilikainen, A.; Kouvalainen, K. Antibody response to pneumococcal vaccine in patients with trisomy-21 (Down’s syndrome). Clin. Exp. Immunol. 1982, 48, 485. [Google Scholar] [PubMed]
- Langkamp, D.L.; Dusseau, A.; Brown, M.F. Vaccine Hesitancy and Low Immunization Rates in Children with Down Syndrome. J. Pediatr. 2020, 223, 64–67. [Google Scholar] [CrossRef] [PubMed]
- Dunn, J.J.; Selvarangan, R.; Maggert, K.; Young, S.; Leber, A.L. Multicenter Evaluation of the DiaSorin Molecular Simplexa Congenital CMV Direct PCR Test on Neonatal Saliva and Urine Specimens. J. Clin. Microbiol. 2023, 61, e00283-23. [Google Scholar] [CrossRef]
- Rawlinson, W.D.; Boppana, S.B.; Fowler, K.B.; Kimberlin, D.W.; Lazzarotto, T.; Alain, S.; Daly, K.; Doutré, S.; Gibson, L.; Giles, M.L.; et al. Congenital cytomegalovirus infection in pregnancy and the neonate: Consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect. Dis. 2017, 17, e177–e188. [Google Scholar] [CrossRef]
- Luck, S.E.; Wieringa, J.W.; Blázquez-Gamero, D.; Henneke, P.; Schuster, K.; Butler, K.; Capretti, M.G.; Cilleruelo, M.J.; Curtis, N.; Garofoli, F.; et al. Congenital cytomegalovirus: A European expert consensus statement on diagnosis and management. Pediatr. Infect. Dis. J. 2017, 36, 1205–1213. [Google Scholar] [CrossRef]
DAY | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
---|---|---|---|---|---|---|---|---|---|---|
WBC cells/xμL) | 16,060 | 20,000 | 26,800 | 28,600 | 26,800 | 19,860 | 14,810 | 13,090 | 9750 | 7300 |
CRP (mg/L) | 22.32 | 22.78 | 21.71 | 23.93 | 22.75 | 18.85 | 14.93 | 12.43 | 7.48 | 3.43 |
PCT (ng/mL) | 3.22 | 3.17 | 2.65 | 1.87 | 1.32 | 1.0 | 0.83 | 0.89 | 0.74 | 0.7 |
CREA (mg/dL) | 1.63 | 2.32 | 2.18 | 1.98 | 1.88 | 2.09 | 2.05 | 1.87 | 1.85 | 1.68 |
CMV DNA Copies/mL (BAL) | 300 2.4 LOG |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Perrotta, F.; Piscopiello, D.; Rizzo, D.; Iosa, G.; Garzya, G.; Calò, P.; Gemma, D. Cytomegalovirus Pneumonia in a Patient with Down Syndrome. Medicina 2024, 60, 242. https://doi.org/10.3390/medicina60020242
Perrotta F, Piscopiello D, Rizzo D, Iosa G, Garzya G, Calò P, Gemma D. Cytomegalovirus Pneumonia in a Patient with Down Syndrome. Medicina. 2024; 60(2):242. https://doi.org/10.3390/medicina60020242
Chicago/Turabian StylePerrotta, Francesco, Donato Piscopiello, Daniela Rizzo, Gaetano Iosa, Giorgio Garzya, Piero Calò, and Daniele Gemma. 2024. "Cytomegalovirus Pneumonia in a Patient with Down Syndrome" Medicina 60, no. 2: 242. https://doi.org/10.3390/medicina60020242